Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/08/2012 | EP1945631B1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
08/08/2012 | EP1942881B1 Compositions and methods for treatment of renal failure |
08/08/2012 | EP1921085B1 Therapeutic agent for hypertension |
08/08/2012 | EP1910274B1 Phenyl compounds |
08/08/2012 | EP1890537B1 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
08/08/2012 | EP1869031B1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
08/08/2012 | EP1868614B1 Dosage regimen for the treatment of a traumatic brain injury with progesterone |
08/08/2012 | EP1861427B1 Agglomerated starch compositions |
08/08/2012 | EP1838296B1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
08/08/2012 | EP1831226B1 Chiral tetracyclic compounds inducing interferon biosynthesis |
08/08/2012 | EP1831221B1 Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
08/08/2012 | EP1824855B1 Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy |
08/08/2012 | EP1819670B1 12-aryl prostaglandin analogs |
08/08/2012 | EP1817276B1 Cathepsin cysteine protease inhibitors |
08/08/2012 | EP1793823B1 Phosphate containing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
08/08/2012 | EP1777217B1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
08/08/2012 | EP1740177B1 Muscarinic acetylcholine receptor antagonists |
08/08/2012 | EP1727545B1 Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
08/08/2012 | EP1678147B1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
08/08/2012 | EP1631670B1 Conserved hbv and hcv sequences useful for gene silencing |
08/08/2012 | EP1624870B1 Dosage form containing (s)-pantoprazole as active ingredient |
08/08/2012 | EP1614419B1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
08/08/2012 | EP1601674B1 Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
08/08/2012 | EP1594508B1 Novel bicyclic compounds and compositions |
08/08/2012 | EP1585518B9 Peptide deformylase inhibitors |
08/08/2012 | EP1581192B1 Improved formulations containing substituted imidazole derivatives |
08/08/2012 | EP1491212B1 Remedy for sleep disturbance |
08/08/2012 | EP1462081B1 Production of ceramide emulsions |
08/08/2012 | EP1458399B1 Pregnane steroids for use in the treatment of cns disorders |
08/08/2012 | EP1453489B1 Acetaminophen compositions |
08/08/2012 | EP1418892B1 Synergistic mixed poloxamer systems for the solubilisation of drugs |
08/08/2012 | EP1404665B1 Antimicrobial compounds |
08/08/2012 | EP1322158B1 Sustained release pharmaceutical compositions containing metformin and method of their production |
08/08/2012 | EP1169038B1 Cyclic protein tyrosine kinase inhibitors |
08/08/2012 | EP1054664B1 Method for modulating macrophage activation |
08/08/2012 | CN202366204U Traditional Chinese medicine bag for treating liver ascites |
08/08/2012 | CN1894221B Reference standard for characterization of rosuvastatin |
08/08/2012 | CN1842323B Method of treating ischemia-reperfusion injury |
08/08/2012 | CN1816331B Tumor-targeting drug-loaded particles |
08/08/2012 | CN1536999B Crystalline forms |
08/08/2012 | CN1439375B Dehydroepiandrosterone treating use and transfer system |
08/08/2012 | CN102630227A Bisphosphonate compounds for treating bone metabolism disorders |
08/08/2012 | CN102630175A Medical use of SPLA2 hydrolysable liposomes |
08/08/2012 | CN102630167A Treatment of neurological conditions |
08/08/2012 | CN102630165A Novel dosing regimen and method of treatment |
08/08/2012 | CN102630162A 4-methylpyrazole formulations |
08/08/2012 | CN102630161A Method of slowing the aging process by activating Sirtuin enzymes with a combination of fucoxanthin and punicic acid |
08/08/2012 | CN102627778A A process for the preparation of cross-linked polyallylamines or pharmaceutically acceptable salts thereof |
08/08/2012 | CN102627683A Triterpenoid saponin compounds with antitumor effects |
08/08/2012 | CN102627682A Esterified and halogenated stigmasterol derivate and application thereof in anti-cancer drugs |
08/08/2012 | CN102627680A Ginsenoside Rg1 compound and pharmaceutical composition containing the same |
08/08/2012 | CN102627676A C-aryl glucoside sglt2 inhibitors and method |
08/08/2012 | CN102627670A Aryl alkyl acid-cyclophosphamide derivative as well as preparation method and application thereof |
08/08/2012 | CN102627669A Phosphate ester-containing piperazine derivative and preparation method as well as application thereof |
08/08/2012 | CN102627660A Cefmetazole aseptic powder and its preparation method |
08/08/2012 | CN102627658A Organic compounds |
08/08/2012 | CN102627654A Human immunodeficiency virus (HIV)-1 protease inhibitors containing isosorbide structural units and preparation method and application thereof |
08/08/2012 | CN102627645A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
08/08/2012 | CN102627642A Metal complexes of moxifloxacin and pharmaceutical purpose thereof |
08/08/2012 | CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents |
08/08/2012 | CN102627638A Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
08/08/2012 | CN102627632A Amino quinazoline derivative and preparation method as well as application thereof |
08/08/2012 | CN102627631A Benzoheterocycle compound and preparation method as well as medical application thereof |
08/08/2012 | CN102627630A Quinolone compounds and their preparation method and use |
08/08/2012 | CN102627625A Schizandrin, schisanhenol and schisandrin-b derivates and application thereof |
08/08/2012 | CN102627624A 4-(4-aminobenzene sulfonamide) phenylacetic acid derivative and preparation method and application thereof |
08/08/2012 | CN102627620A One type of benzofuran derivatives and medical application thereof |
08/08/2012 | CN102627614A Diquinazoline diselenide compound as well as preparation method and bioactivity thereof |
08/08/2012 | CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application |
08/08/2012 | CN102627611A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one |
08/08/2012 | CN102627610A One type of benzimidazole derivatives and application thereof |
08/08/2012 | CN102627609A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
08/08/2012 | CN102627607A 5HT2c receptor modulator compositions and methods of use |
08/08/2012 | CN102627605A Huperzine A polymorph, its preparation method, medicinal composition containing huperzine A polymorph and its application |
08/08/2012 | CN102627604A Two types of isoquinoline compounds and application thereof to preparing anti-cancer medicaments |
08/08/2012 | CN102627603A Process of making crystalline aripiprazole |
08/08/2012 | CN102627593A 1,4-dihydroxy-2-formyl-9,10 anthraquinone thiosemicarbazone new compound with anticancer activity and preparation method thereof |
08/08/2012 | CN102627578A Phenyl benzylamine compound and application thereof |
08/08/2012 | CN102626524A Chitosan gynaecologic antibacterial gel and preparation method thereof |
08/08/2012 | CN102626521A Segmented copolymer - docetaxel combination, preparation thereof and preparation method thereof |
08/08/2012 | CN102626512A Preparation method for traditional Chinese medicine lotion for treating malnutritional pustule on sole |
08/08/2012 | CN102626482A Application of Chinese medicinal composition to preparation of medicament for treating and improving lung PM2.5 deposition |
08/08/2012 | CN102626466A Chinese medicinal regulating oral liquid |
08/08/2012 | CN102626454A Traditional Chinese medicine combination for treating erysipelas |
08/08/2012 | CN102626443A Chinese herbal medicine combination for treating gout |
08/08/2012 | CN102626441A Antipyrotic powder for external use |
08/08/2012 | CN102626427A Ginkgo dipyridamole composition and preparation method of preparation thereof |
08/08/2012 | CN102626424A Active bacteriostasis capsule |
08/08/2012 | CN102626423A Compound preparation containing heptaene menadione and application thereof |
08/08/2012 | CN102626420A Mixed preparation containing strontium, calcium and vitamin D |
08/08/2012 | CN102626419A Compound preparation for treating edema diseases of pigs and preparation method thereof |
08/08/2012 | CN102626418A Application of pyrola polysaccharide in preparing immunity-enhancing medicaments and health food |
08/08/2012 | CN102626417A Use of arctiin in preparation of drug or health food |
08/08/2012 | CN102626416A Application of tamoxifen, rapamycin and ginsenoside Rg3 composition in preparing medicaments for treating liver cancer |
08/08/2012 | CN102626415A Application of combination of tetracycline medicine and fluconazole in preparation of antifungal product, and product thereof |
08/08/2012 | CN102626414A Compound salicylic acid and clotrimazole aerosol |
08/08/2012 | CN102626413A Application of phenoxyl pyridine derivative |
08/08/2012 | CN102626412A Pharmaceutical composition for curing malignant tumor |
08/08/2012 | CN102626411A Pharmaceutical composition containing propofol and opioid analgesics and use thereof |
08/08/2012 | CN102626410A Pharmaceutical composition containing roflumilast |